When Inflammation Isn’t an Attack — It’s Gridlock

What a new Science study reveals about obesity, mitochondria, and why inflammation won’t turn off

Low-grade inflammation is one of the most consistent features of obesity. It shows up in blood tests, adipose tissue, the liver, the brain — and it strongly predicts diabetes, cardiovascular disease, fatty liver disease, and even neurodegeneration.

But one question has lingered for years:

Why does inflammation persist even when there’s no infection to fight?

A new study published in Science (January 2026) offers an important piece of the answer — and when viewed through an Exposure-Related Malnutrition (ERM) and bioenergetic congestion lens, the findings become even more revealing.

This is not a story about an immune system “overreacting.”

It’s a story about cells stuck in survival mode, unable to resolve stress.

The study in brief: what the authors found

Researchers compared immune cells (macrophages) from lean and obese humans and animal models. They discovered that in obesity:

• The NLRP3 inflammasome — a key inflammatory signaling complex — is hyperactivated

• Macrophages accumulate excess mitochondrial DNA (mtDNA), much of it oxidized

• A normally protective enzyme, SAMHD1, which degrades excess DNA building blocks (dNTPs), is functionally disabled

• Excess dNTPs flood into mitochondria, fueling uncontrolled mtDNA synthesis

• Oxidized mtDNA then amplifies NLRP3 activation, driving persistent IL-1β release

Blocking the transport of dNTPs into mitochondria sharply reduced inflammation — even in immune cells taken directly from obese patients.

On the surface, this looks like a new molecular switch for inflammation.

But zooming out tells a deeper story.

Reframing the findings: inflammation as a consequence of congestion

ERM logic starts with one question:

What happens when energy demand stays high, but mitochondrial throughput is constrained?

In obesity — and many chronic stress states — mitochondria are not “dead,” but overloaded:

• Electron transport is inefficient

• Redox balance is fragile

• ATP is sufficient for survival, but not for full repair and resolution

This creates bioenergetic congestion — a mismatch between inputs and throughput.

Under these conditions, cells do not shut down.

They adapt.

mtDNA synthesis as a compensatory response — not the original problem

Increasing mitochondrial DNA copy number makes intuitive sense under stress:

If each respiratory unit isn’t producing enough energy, make more of them.

This is a compensatory strategy, similar to:

• Mitochondrial biogenesis signaling

• Cristae remodeling

• Shifts toward glycolysis

The problem isn’t mtDNA synthesis itself.

The problem is doing it when energy flow and redox capacity can’t support it.

That’s where SAMHD1 enters the picture.

SAMHD1: a brake that prevents pseudo-repair

Under normal conditions, SAMHD1:

• Degrades excess dNTPs

• Prevents unnecessary DNA synthesis

• Keeps anabolism matched to real repair demand

In obesity, the study shows that SAMHD1 is phosphorylated and disabled.

This doesn’t initiate inflammation.

It removes a constraint.

Once that brake is gone:

• dNTPs accumulate

• mtDNA synthesis becomes supply-driven

• New mtDNA is produced under oxidatively stressed conditions

• Oxidized mtDNA accumulates and leaks

At this point, inflammation is no longer about danger detection — it’s about failed resolution.

One-carbon metabolism: the hidden overflow pathway

There’s another layer here that the paper implies but doesn’t explicitly name.

DNA synthesis — both nuclear and mitochondrial — pulls heavily on one-carbon metabolism:

• Folate cycle

• Methionine cycle

• SAM (methyl donor) production

Under congestion, one-carbon metabolism acts as a substrate sink:

• Absorbs excess carbon and nitrogen

• Consumes ATP and NAD(P)H

• Sustains transcription and biosynthesis even when repair can’t complete

This keeps the system “busy,” but not healed.

The result is a biochemical pattern seen across chronic disease:

• Persistent inflammation

• Epigenetic drift and hypermethylation

• Stable stress-adapted gene expression

Again: adaptation without resolution.

ISR as the initiator, mtDNA as the amplifier

This is where the Integrated Stress Response (ISR) helps clarify causality.

The ISR is activated when cells sense:

• Energy shortage

• Redox imbalance

• Protein folding stress

• Mitochondrial dysfunction

Its purpose is to:

• Pause growth

• Reprioritize survival

• Hold the system together

From this perspective:

• ISR activation is the initiator

• NLRP3 is a downstream reporter of unresolved stress

• SAMHD1 disablement and oxidized mtDNA are augmenters

They don’t flip inflammation “on.”

They turn the volume up and prevent it from turning off.

This explains why:

• Inflammation persists without infection

• Blocking NLRP3 alone often gives incomplete benefit

• Restoring energy flow is more effective than suppressing signals

Translational implications: where intervention really matters

This reframing shifts therapeutic priorities.

Instead of asking:

How do we block inflammation?

We should ask:

How do we restore throughput so inflammation can safely turn off?

Potential leverage points include:

• Restoring mitochondrial redox balance and OXPHOS efficiency

• Reducing chronic substrate oversupply

• Supporting rhythmic catabolic–anabolic cycling (sleep, fasting, recovery)

• Avoiding interventions that increase anabolism without improving throughput

• Targeting amplifiers (like nucleotide overflow) rather than suppressing immune sensing itself

Blocking mitochondrial dNTP transport worked in this study — not because it “fixed immunity,” but because it reduced congestion.

The bigger message

This study doesn’t just explain inflammation in obesity.

It supports a broader principle:

Chronic inflammation often reflects a system stuck in adaptation mode, not one that is broken or overreacting.

When energy can flow again,

when repair can complete,

when congestion clears —the immune system knows how to stand down.

You’re not broken.

You’re exhausted — and exhaustion has chemistry.

Liu, D., Zhou, C., Wang, X., Luo, Z., Xu, R., Huo, S., Guo, L., Luo, X., Yang, S., et al. (2026). Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity. Science, 391(6782), Article adq9006. https://doi.org/10.1126/science.adq9006